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Introduction
============

Diabetes mellitus (DM) is a chronic disorder which cannot be cured, but is managed with modifying lifestyle to maintain blood sugar levels within the normal range. The conventional method of managing type 2 DM (T2DM) involves oral glucose lowering drugs and/or insulin therapy. Despite decades of research and development of new classes of anti-diabetic drugs, managing diabetes effectively remains a grave challenge for clinicians. Therapeutic compliance, medication access, counseling, regular monitoring of blood sugar levels, access to health care services, and quality of management are some factors governing the efficacy of diabetes treatment \[[@REF1]\].

However, not all patients are benefitted by conventional anti-diabetic therapy and some patients of T2DM were supplemented with complementary alternative medicines (CAM) in addition to conventional medicines \[[@REF2]\]. Wanchai and Phrompayak made two categories of CAM therapy - natural products and practices of mind and body. Herbs, minerals and vitamins, essential oils, and probiotics are included in natural products. Practices of mind and body vary according to individual needs and include yoga, chiropractic manipulation, meditation, massage, acupuncture, cupping, and many more \[[@REF2]\]. In a study with patients of chronic diseases, 64% were found to be using CAM. Out of these, 35.5% were using CAM for diabetes mellitus. They reported vitamins (48.2%) and herbal medicines (26.4%) as commonly used CAM. Higher education status, higher income, and aged above 50 years were independently associated with CAM use. Many patients (77.6%) reported improved condition with use of CAM \[[@REF3]\].

Although patients might perceive natural products of CAM to be safer and more effective as compared to pharmaceutical drugs and may use them to alleviate symptoms of chronic diseases, some have deduced that CAM may worsen health. In a study with diabetic patients, CAM users were associated with poor glycemic control and higher disease severity \[[@REF4]\]. In another study with 29% diabetics using CAM for diabetes specifically, CAM users had poor cardiometabolic control with elevated low density lipoproteins and poor medication adherence \[[@REF5]\]. The aim of this study was to evaluate knowledge, attitude, practices (KAP) of diabetic patients towards use of CAM products.

Materials and methods
=====================

It was an observational, prospective, cross-sectional study conducted in the institute of diabetology in a tertiary care hospital in Pakistan. Data was collected from 1st March 2018 till 31st August 2018. Non-randomized, convenient, consecutive sampling technique was utilized. Informed verbal consent was obtained from all participants and ethical approval institutional review board was obtained.

All patients of type 2 diabetes mellitus attending the clinic for routine follow-up visits during the study period were interviewed. Their demographic characteristics including gender, age, marital status, education status, employment status, and smoking status were recorded. Clinical characteristics included in the study were duration of T2DM, mode of treatment of T2DM (oral medications and/or insulin), complications associated with T2DM, glycemic control, and other medical co-morbidities. In order to assess KAP of the participants towards use of CAM products, questionnaire was adapted from Al-Eidi et al. \[[@REF6]\]. There were three questions regarding knowledge, four regarding attitude, and seven reasons of the attitude. For participants who practiced CAM use, type of CAM, recommender of CAM, and user behaviour was assessed \[[@REF6]\].

Data was managed using SPSS for Windows version 16.0 (SPSS Inc, Chicago, IL). For continuous variables, mean and standard deviation was calculated. For categorical variables, frequency and percentages were calculated. Demographic data, clinical data, and KAP characteristics were correlated with the use of CAM using Pearson's Chi-square test. P value ≤0.05 was taken as significant. Odds ratio (OR) along with confidence interval (CI) was considered as determinants of strength.

Results
=======

Two hundred and ninety-three participants were approached for the study. Fifteen participants refused and 17 responses were omitted due to incomplete information. Remaining 261 responses were included in the analysis. There were 159 (60.9%) men and 102 (39.1%) women. Their mean age was 61 ± 13 years (range: 54-78 years). Most of the participants were of age more than 60 years. More than half of the sample was married (64.7%). About 14.5% participants were uneducated and 41% were employed. All patients were diagnosed with T2DM; 8% were newly diagnosed. The mean duration of diagnosis was 8.6 ± 3.7 years (range: 0-17 years). About half of the patients (49%) were taking oral anti-diabetic medications and more than 35% had developed diabetes-related complications. The most common complication was peripheral neuropathy (43%). Adequate glycemic control was present in 34%. Other medical conditions were present in 185 (70.9%) participants. All demographic and clinical characteristics of the patients were summarized in Table [1](#TAB1){ref-type="table"}.

###### Frequency of socio-demographic and clinical characteristics of the participants (N = 261)

HbA1c: Glycosylated haemoglobin type A1c; T2DM: Type 2 diabetes mellitus.

  ----------------------------------- ---------------------------- ----------------------------- -----------------
  Sociodemographic characteristics    Frequency n (%)              Clinical characteristics      Frequency n (%)
  Gender                              Duration of T2DM diagnosis                                 
  Male                                159 (60.9%)                  Newly diagnosed               21 (8.1%)
  Female                              102 (39.1%)                  \<5 years                     87 (33.3%)
  Age                                 5 to \<10 years              101 (38.7%)                   
  ≤40 years                           52 (19.9%)                   Greater than 10 years         52 (19.9%)
  41-59 years                         96 (36.7%)                   Medications used for T2DM     
  ≥60 years                           113 (43.3%)                  Oral hypoglycemic drugs       128 (49.1%)
  Marital status                      Insulin                      82 (31.4%)                    
  Married                             169 (64.7%)                  Both                          51 (19.5%)
  Never married                       28 (10.7%)                   T2DM-related complications    
  Divorced/Widowed                    64 (24.5%)                   No                            170 (65.1%)
  Education                           Yes                          91 (34.8%)                    
  Illiterate                          38 (14.5%)                   T2DM complications (n = 91)   
  Primary / secondary / high school   128 (49.1%)                  Peripheral neuropathy         29 (43.3%)
  Bachelors and above                 95 (36.3%)                   Cardiovascular disease        19 (28.3%)
  Employment status                   Diabetic foot wound/ulcer    18 (26.9%)                    
  Employed                            107 (41.0%)                  Retinopathy                   16 (23.8%)
  Unemployed                          62 (23.7%)                   Nephropathy                   8 (11.9%)
  Retired                             92 (35.2%)                   Others                        1 (1.4%)
  Smoking status                      Glycemic control                                           
  Smoker                              104 (39.8%)                  HbA1c ≤ 7%                    89 (34.1%)
  Non-smoker                          58 (22.2%)                   HbA1c \> 7%                   172 (65.9%)
  Ex-smoker                           99 (37.9%)                   Medical Co morbidity status   
                                      Hypertension                 122 (46.7%)                   
  Hyperlipidemia                      111 (42.5%)                                                
  Ischemic heart disease              109 (41.7%)                                                
  Obesity                             98 (37.5%)                                                 
  Others                              12 (4.6%)                                                  
  ----------------------------------- ---------------------------- ----------------------------- -----------------

In Table [2](#TAB2){ref-type="table"}, the knowledge, attitude and reasons of attitude of the study participants towards the use of complementary medications for T2DM are summarized. Almost all of the patients (n = 260; 99.6%) had heard of CAM and half of the sample (n = 112; 42.9%) knew that CAM can be effective and 101 (38.7%) believed that CAM were safe for them. When the attitude of participants was assessed towards use of CAM, it was deduced that 77% would first discuss using CAM with their current physician, 8% would use CAM even if their physicians did not advise them to, and 49% will also use their T2DM medications along with CAM. Majority of the patients (57.5%) mentioned that they will use CAM because of lesser side effects and 49% believed that CAM will help control their blood sugar levels. Delayed doctor appointment was an important reason in 35% participants, cost was a factor in 28%, poor physician-patient relationship in 4%, lack of trust in modern medicines in 19.5%, and in 2.3% cases the doctors recommended using CAM to the patients. All responses of knowledge, attitude, and reasons of attitude are summarized in Table [2](#TAB2){ref-type="table"}.

###### Knowledge, attitude, and reasons of attitude of the participants regarding complementary alternative medications (N = 261)

CAM: Complementary alternative medications; T2DM: Type 2 diabetes mellitus.

  ----------------------------------------------------------------------- -----------------
  Variables                                                               Frequency n (%)
  Knowledge                                                               
  Have you heard of CAM?                                                  260 (99.6%)
  Do you believe that CAM products are effective?                         112 (42.9%)
  Do you believe that CAM products are safe?                              101 (38.7%)
  Attitude                                                                
  If you want to use CAM, will you discuss with the physician?            201 (77.1%)
  If you want to use CAM, will you combine it with T2DM medications?      129 (49.4%)
  Will you advise a family member with T2DM to use CAM?                   82 (31.4%)
  If your physician instructs you not to use CAM, would you follow him?   21 (8.1%)
  Reasons of attitude                                                     
  Believe CAM have fewer side effects                                     150 (57.5%)
  Believe CAM can help the diabetes control                               128 (49.1%)
  Long appointment intervals to see physician                             92 (35.2%)
  CAM are easily available and cheaper                                    72 (27.6%)
  Lack of trust in pharmaceutical drugs                                   51 (19.5%)
  Poor physician-patient communication                                    10 (3.8%)
  Doctor suggested using CAM                                              6 (2.3%)
  Using CAM for T2DM                                                      
  Yes                                                                     151 (57.8%)
  No                                                                      90 (34.5%)
  ----------------------------------------------------------------------- -----------------

As seen in Table [2](#TAB2){ref-type="table"}, 151 (57.8%) participants claimed that they use alternative medicines. Out of these, 82 \[82/151 (54.3%); 82/261 (31.4%)\] patients claimed that they were using CAM for their diabetes. The practices of these patients are summarized in Table [3](#TAB3){ref-type="table"} which shows that herbs (n = 121; 80.1%) were the most common form of CAM used. Other family members (n = 44; 29.1%) and traditional healers (n = 38; 25.2%) commonly recommended CAM. In two (1.3%), the physicians had prescribed CAM. There were only 41/151 (27%) patients who were combining their CAM with T2DM medications, rest were using CAM alone, 24% claimed that they will continue to use CAM, 19% were satisfied with their products, and 14.5% had discussed using CAM with their physicians. The characteristics of CAM users are summarized in Table [3](#TAB3){ref-type="table"}.

###### Responses of participants who use complementary alternative medications (N = 151)

Responses may be more or less than 151 due to multiple preferences.

CAM: Complementary alternative medications; T2DM: Type 2 diabetes mellitus

  --------------------------------------------------------- -----------------
  Variables                                                 Frequency n (%)
  CAM Practices used                                        
  Herbs                                                     121 (80.1%)
  Treatments based in a specific diet                       98 (64.9%)
  Cupping                                                   68 (45.0%)
  Nutritional supplements (vitamins and minerals)           28 (18.5%)
  Spiritual healing                                         26 (17.2%)
  Honeybee products                                         12 (7.9%)
  Medical massage                                           10 (6.6%)
  Recommendation of CAM given by                            
  Family                                                    44 (29.1%)
  Traditional healer                                        38 (25.2%)
  Friend                                                    24 (15.9%)
  Pharmacist                                                20 (13.2%)
  Herbalist                                                 19 (12.6%)
  Dietician                                                 4 (2.6%)
  Physician                                                 2 (1.3%)
  User behaviour                                            
  Have you ever used CAM for a condition other than T2DM?   101 (66.8%)
  Have you ever used CAM for T2DM?                          82 (54.3%)
  Do you combine CAM and T2DM medication?                   41 (27.2%)
  Will you use CAM product again?                           36 (23.8%)
  Are you satisfied with the CAM products?                  29 (19.2%)
  Do you discuss with physician about CAM products?         22 (14.5%)
  --------------------------------------------------------- -----------------

Demographic characteristics, knowledge, attitude, and practices of the participants were correlated with use of CAM. Demographic and clinical characteristics which showed significant association to the use of CAM were gender (p \< 0.000; OR 0.24; CI 0.14, 0.42), age (p \< 0.000), marital status (p = 0.04), education status (p \< 0.000), employment status (p \< 0.000), duration of diabetes (p \< 0.000), diabetes-related complications (p \< 0.000; OR 2.57; CI 1.53, 4.34), and glycemic control (p \< 0.000; OR 0.29; CI 0.17, 0.5). KAP-related characteristics which were significantly correlated with the use of CAM included lack of trust in pharmaceutical products (p \< 0.000; OR 5.08; CI 2.28, 11.32), longer time intervals to see physicians (p = 0.001; OR 0.43; CI 0.26, 0.72), poor patient-doctor relationship (p = 0.06; OR 1.47; CI 0.26, 8.17), CAM products being readily available and cheaper (p \< 0.000; OR 6.1; CI 3.02, 12.32), and belief that CAM products have fewer side effects (p \< 0.000; OR 12.32; CI 6.83, 22.22) and can help in diabetes control (p \< 0.000; OR 35.76; CI 16.79, 76.15) (Table [4](#TAB4){ref-type="table"}).

###### Relationship of participants characteristics with usage of complementary alternate medicines (N = 261)

CAM: Complementary alternative medications; CI: Confidence interval; T2DM: Type 2 diabetes mellitus.

  ---------------------------------------------- --------------------- ------------- ------------- ------------ ---------- --------------
  Variables                                      Frequency n (%)       Use of CAM    P value       Odds Ratio   CI (95%)   
  Yes (n = 151; 57.8%)                           No (n = 110; 42.1%)                                                       
  Gender                                                                                                                   
  Male                                           159 (60.9%)           72 (45.3%)    87 (54.7%)    \<0.000      0.24       0.14, 0.42
  Female                                         102 (39.1%)           79 (77.4%)    23 (22.5%)                            
  Age in years                                                                                                             
  ≤40 years                                      52 (19.9%)            18 (34.6%)    34 (65.3%)    \<0.000      NA         NA
  41-59 years                                    96 (36.7%)            49 (51.0%)    47 (49.0%)                            
  ≥60 years                                      113 (43.3%)           84 (74.3%)    29 (25.7%)                            
  Marital status                                                                                                           
  Married                                        169 (64.7%)           97 (57.4%)    72 (42.6%)    0.04         NA         NA
  Never married                                  28 (10.7%)            11 (39.3%)    17 (60.7%)                            
  Divorced / Widowed                             64 (24.5%)            43 (67.2%)    21 (32.8%)                            
  Education                                                                                                                
  Illiterate                                     38 (14.5%)            29 (76.3%)    9 (23.7%)     \<0.000      NA         NA
  Primary / secondary / high school              128 (49.1%)           95 (74.2%)    33 (25.8%)                            
  Bachelors and above                            95 (36.3%)            27 (28.4%)    68 (71.6%)                            
  Employment status                                                                                                        
  Employed                                       107 (41.0%)           35 (32.7%)    72 (67.2%)    \<0.000      NA         NA
  Unemployed                                     62 (23.7%)            48 (77.4%)    14 (22.6%)                            
  Retired                                        92 (35.2%)            68 (73.9%)    24 (26.1%)                            
  Duration of T2DM diagnosis                                                                                               
  Newly diagnosed                                21 (8.1%)             7 (33.3%)     14 (66.7%)    \<0.000      NA         NA
  \<5 years                                      87 (33.3%)            37 (42.5%)    50 (57.5%)                            
  5 to \<10 years                                101 (38.7%)           68 (67.3%)    33 (32.7%)                            
  Greater than 10 years                          52 (19.9%)            39 (75.0%)    13 (25.0%)                            
  Medications used for T2DM                                                                                                
  Oral hypoglycemic drugs                        128 (49.1%)           68 (53.1%)    60 (46.9%)    0.25         NA         NA
  Insulin                                        82 (31.4%)            53 (64.6%)    29 (35.4%)                            
  Both                                           51 (19.5%)            30 (58.8%)    21 (41.2%)                            
  T2DM-related complications                                                                                               
  No                                             170 (65.1%)           112 (65.9%)   58 (34.1%)    \<0.000      2.57       1.53, 4.34
  Yes                                            91 (34.8%)            39 (42.9%)    52 (57.1%)                            
  Glycemic control                                                                                                         
  HbA1c ≤ 7%                                     89 (34.1%)            34 (38.2%)    55 (61.8%)    \<0.000      0.29       0.17, 0.5
  HbA1c \> 7%                                    172 (65.9%)           117 (68.1%)   55 (31.9%)                            
  Medical comorbidities                                                                                                    
  Yes                                            185 (70.9%)           103 (55.7%)   82 (44.3%)    0.26         0.73       0.42, 1.27
  No                                             76 (26.1%)            48 (63.2%)    28 (36.9%)                            
  Lack of trust in pharmaceutical drugs                                                                                    
  Yes                                            51 (19.5%)            43 (84.3%)    8 (15.7%)     \<0.000      5.08       2.28, 11.32
  No                                             210 (80.5%)           108 (51.4%)   102 (48.6%)                           
  Waiting time intervals to see physicians                                                                                 
  Yes                                            92 (35.2%)            41 (44.6%)    51 (55.4%)    0.001        0.43       0.26, 0.72
  No                                             169 (64.8%)           110 (65.1%)   59 (34.9%)                            
  Poor physician-patient communication                                                                                     
  Yes                                            10 (3.8%)             3 (%)         7 (%)         0.06         0.3        0.08, 1.18
  No                                             251 (96.2%)           148 (%)       103 (%)                               
  Doctor suggesting it                                                                                                     
  Yes                                            6 (2.3%)              4 (%)         2 (%)         0.65         1.47       0.26, 8.17
  No                                             255 (97.7%)           147 (%)       108 (%)                               
  Availability and better value for money                                                                                  
  Yes                                            72 (27.6%)            61 (%)        11 (%)        \<0.000      6.1        3.02, 12.32
  No                                             189 (72.4%)           90 (%)        99 (%)                                
  Belief in that CAM has fewer side effects                                                                                
  Yes                                            150 (57.5%)           122 (%)       28 (%)        \<0.000      12.32      6.83, 22.22
  No                                             111 (42.5%)           29 (%)        82 (%)                                
  Belief in that CAM can help diabetes control                                                                             
  Yes                                            128 (49.1%)           118 (%)       10 (%)        \<0.000      35.76      16.79, 76.15
  No                                             133 (50.9%)           33 (%)        100 (%)                               
  ---------------------------------------------- --------------------- ------------- ------------- ------------ ---------- --------------

Discussion
==========

Almost one-third of all diabetic patients were found to be using CAM for their diabetes. Herbs and specific diets were common modes of CAM practices. Family members were the common recommenders of CAM. Use of CAM showed significant association with female gender, older age, divorced/widow marital status, lower education, unemployment, longer duration of diabetes, diabetes-related complications and poor glycemic control. KAP-related characteristics which were significantly correlated with the use of CAM included lack of trust in pharmaceutical products, longer time intervals to see physicians, poor patient-doctor relationship, CAM products being readily available and cheaper, and belief that CAM products have fewer side effects and can help in diabetes control.

To the best of our knowledge, this is the first study to provide detailed report of KAP of Pakistani diabetic individuals regarding the use of CAM. Kamran et al. have recently published a significant report regarding the pattern of CAM practices and CAM-related beliefs among diabetic patients in Pakistan \[[@REF7]\]. However, this study was conducted in one centre only and its results cannot be generalized. Furthermore, it included all patient characteristics on one instance only and did not follow the patients over time to study the actual effects of CAM on their health. Other causes of poor glycemic control and diabetes-related complications cannot be eliminated.

In a qualitative analysis from Pakistan, religious practices (37.5%), herbal (15.5%), and household remedies (9.4%) were the main CAM practices among diabetic patients. Patients reported that their practices had significant positive impacts on their health. The main motivator of CAM use was the desire to find cure of diabetes. This desire was strongly triggered by pressure from the family and community \[[@REF8]\]. In another recent analysis from Pakistan, 41% patients supported combination of CAM and conventional therapy for T2DM and only 3% supported CAM alone. A slight majority (55%) trusted CAM for T2DM, 47% favored CAM, and 49% observed no change in their diabetes with CAM. Prayers, herbs (bitter gourd), and multivitamins were the commonly used modes of CAM \[[@REF7]\]. In another local analysis, more than half (53%) diabetics were using CAM. Less education and concomitant kidney disease were important predictors of CAM use \[[@REF9]\].

In a KAP study from Saudi Arab, almost all patients knew about CAM, 27% found them safe, and 26% found them effective. A high majority (90%) reported that they will first discuss CAM usage with their physicians and 44% preferred combining CAM with their conventional therapy. Herbs were the most common CAM (31%), followed by wet cupping (20.5%) and nutritional supplements (18%) \[[@REF6]\]. In another Saudi meta-analysis, the overall frequency of CAM use in diabetic patients was 32% with herbs including fenugreek and black seeds being the most common \[[@REF10]\]. Predictors of CAM use were age above 51 years, unemployment, and the participants' knowledge about the effectiveness of CAM products \[[@REF6]\]. Herbs and specific diets were also the common mode of CAM in this study. However, in a study with Thai diabetics, Tai chi (a form of Chinese martial arts), prayer, and meditation were the common practices. They reported female gender, age 40-69 years, and diabetes duration less than 10 years as significant correlators of CAM use \[[@REF2]\]. Female gender and older age was also correlated with CAM use in our study, but results were contradictory as far as duration of diabetes is concerned.

In a Nigerian study, 67% diabetics were using herbal products for glycemic control. Out of these, only 32% had disclosed it to their physicians. The common reasons included safety (74%) and affordability (60%). They reported older age, less education, longer duration of diabetes, diabetes management using oral hypoglycaemics, family history of diabetes, and neuropathy as predictors of herbal medicine use \[[@REF1]\]. In another Nigerian study, use of CAM resulted in better glycemic control and an improved lipid profile \[[@REF11]\]. The results are contrary to our study where users of CAM depicted worse glycemic control. Poor glycemic and cardiometabolic control with CAM has been established in other studies too \[[@REF4],[@REF5]\]. In an Iranian study, glycemic control and foot care had the strongest positive correlations with religious practices \[[@REF12]\]. Wet and dry cupping therapies also known as Hijama are also becoming popular in alternative treatment of diabetes \[[@REF13]\]. Cupping therapy in diabetic patients resulted in significant reduction in their hemoglobin A1C, pre-prandial and post-prandial blood sugar levels, serum triglyceride, serum cholesterol, low density lipoprotein and espartos transferees. There was a significant increase in high density lipoproteins \[[@REF14]\].

Use of complementary and alternative medicines for chronic illnesses including diabetes mellitus is becoming more popular day by day. With evolving patient preferences, clinicians as well as researchers have to shift their focus to this mode of treatment. Clinicians should encourage healthy discussions with the patients to comprehend their views regarding CAM. Clinicians and researchers should join hands to initiate safety and efficacy trials on common herbal products used for diabetes. Presence of concrete evidence in the form of randomized controlled trials will help both patients and clinicians regarding use of a certain complementary medicine product.

Conclusions
===========

Use of complementary medicine products among Pakistani diabetic population is high. Herbs and specific diets were common modes of CAM practices. Use of CAM showed significant association with female gender, older age, lower education, unemployment, longer duration of diabetes, diabetes-related complications, and poor glycemic control. KAP-related characteristics which were significantly correlated with the use of CAM included lack of trust in pharmaceutical products, longer time intervals to see physicians, poor patient-doctor relationship, CAM products being readily available and cheaper, and belief that CAM products have fewer side effects and can help in diabetes control.
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